OREX
Orexigen Therapeutics, Inc.
OREX
OREX
Delisted
OREX was delisted on the 3rd of April, 2018.
132 hedge funds and large institutions have $234M invested in Orexigen Therapeutics, Inc. in 2015 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 51 increasing their positions, 41 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
59% less capital invested
Capital invested by funds: $564M → $234M (-$330M)
67% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 42
Holders
132
Holding in Top 10
2
Calls
$3.02M
Puts
$3.52M
Top Buyers
| 1 | +$9.17M | |
| 2 | +$4.98M | |
| 3 | +$2.33M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
+$1.98M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$1.85M |
Top Sellers
| 1 | -$26.1M | |
| 2 | -$11.7M | |
| 3 | -$4.95M | |
| 4 |
CPIM
Columbia Partners Investment Management
Alexandria,
Virginia
|
-$4.54M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$3.2M |